Font Size: a A A
Keyword [Anti-tuberculosis drug]
Result: 21 - 40 | Page: 2 of 3
21. Relationships Of CYP 450 Gene Polymorphisms With Anti-tuberculosis Drug-induced Liver Injury
22. Analysis Of The Mid-term Efficacy Of Posterior Transpedicular Debridement, Anti-tuberculosis Drug Bone Cement Mixture Implantation, And Pedicle Screw Fixation For Spinal Tuberculosis
23. Comparison Of The Efficacy Of Operation Combined With Anti-Tuberculosis Drugs And Pure Anti-Tuberculosis Drugs In The Treatment Of Cavitary Tuberculosis
24. Study On The Correlation Between Allergy Constitution And Adverse Reactions Of Anti-tuberculosis Drugs
25. Study On Expression And Antibacterial Effect Of Mycobacterium Phage Guo1 LysA
26. Expression And Function Of Circular RNA Hsacirc0011940 In Peripheral Blood Of Patients With Anti-tuberculosis Drug-induced Liver Injury
27. Analysis Of Second-Line Anti-Tuberculosis Drug Resistance Characteristics And Associated-Genes Of Clinical Mycobacterium Tuberculosis Isolates From Hebei Province
28. Retrospective Analysis Of Anti-tuberculosis Drug-induced Hepatotoxicity In Children
29. The Diagnostic Value And Mechanism Of Circular RNA CircMARS And CircITPR1 In Anti-tuberculosis Drug-induced Liver Injury
30. Retrospective Study On First-line Anti-tuberculosis Drug Resistance Of Inpatients In A Tuberculosis Hospital In Jiangxi Province
31. Clinical Characteristics And Genetic Polymorphism Of Antituberculous Drug-induced Hepatotoxicity In Children
32. Protoporphyrin ? Accumulation Induced Liver Injury After Receiving A HRZE Antitubercular Regimen
33. Trends in anti-tuberculosis drug resistance from 2003--2007 at Pham Ngoc Thach tuberculosis and lung disease hospital, Ho Chi Minh City, Vietnam
34. Study On The Distribution Of Body Constitution In Patients With Anti-tuberculosis Drug-induced Liver Injury And Its Correlation With ABC Transporter SNP
35. Analysis Of Risk Factors For Anti-tuberculosis Drug-induced Liver Injury In Patients With Primary Anti-tuberculosis Treatment
36. The Effect Of Conventional Anti-tuberculosis Drug Therapy On Sputum And Gut Microbiota
37. Characteristics And Risk Factors Of First Line Anti-tuberculosis Drug Induced Liver Injury
38. Study Of HMGB1-RAGE Signal Pathway In The Prevention Of Anti-Tuberculosis Drug-Induced Liver Injury With Orazamide
39. Association Study Of ABO Blood Group,HMOX1 And HPX Gene Polymorphism With Antituberculosis Drug-induced Liver Injury
40. Study On The Relationship Between Baseline VD Nutritional Status And The Risk Of Anti-tuberculosis Drug Induced Liver Injury And The Possible Mechanism
  <<First  <Prev  Next>  Last>>  Jump to